http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105592850-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d6ad28bb9393fc944d64dc31284aeac
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C53-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
filingDate 2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9a03c505f16757e8a1281263b5dc8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d2a823f00108f72c07b8dda15096b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5fb3f83c9f777e4a9bc2e3b9e485960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_010f28e749794ac05129b395e5e47a85
publicationDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105592850-A
titleOfInvention Inhibitors of ACK1/TNK2 tyrosine kinases
abstract Cancer therapies and anticancer compounds are described. In particular, inhibitors of ACK1 tyrosine kinase and their use in the treatment of cancer are disclosed. Also disclosed are methods of screening novel ACK1 tyrosine kinase inhibitors. In particular examples, compounds having Formulas I-IV are disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108299312-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108299312-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110396065-A
priorityDate 2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103038230-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101031551-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466803245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163682100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466389300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465329344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466389428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163738220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466842923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465409907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466138159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467341864

Total number of triples: 35.